OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020
Preeti Pathela, Addie Crawley, Don Weiss, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 2, pp. 196-206
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 348-357
Open Access | Times Cited: 146

Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial
Dean Follmann, Holly Janes, Olive D. Buhule, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1258-1265
Open Access | Times Cited: 106

Predictors of Nonseroconversion after SARS-CoV-2 Infection
Wei‐Min Liu, Ronnie M. Russell, Frédéric Bibollet‐Ruche, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 9, pp. 2454-2458
Open Access | Times Cited: 60

Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile
Pablo Vial, Claudia González, Gloria Icaza, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27

Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June–October 2020: A Population-Based Survey
Jannae C. Parrott, Ariana N. Maleki, Valerie E Vassor, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 2, pp. 188-195
Open Access | Times Cited: 29

One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk
Christine Klein, Max Borsche, Alexander Balck, et al.
Science Advances (2022) Vol. 8, Iss. 15
Open Access | Times Cited: 19

Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022
Sharon K. Greene, Alison Levin‐Rector, Nang Thu Thu Kyaw, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 19

Development of hybrid immunity during a period of high incidence of Omicron infections
Anja Frei, Marco Kaufmann, Rebecca Amati, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 6, pp. 1696-1707
Open Access | Times Cited: 11

Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022
Saba A Qasmieh, McKaylee Robertson, Chloe A. Teasdale, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e499-e502
Open Access | Times Cited: 14

Longitudinal Study on Seroprevalence and Immune Response to SARS-CoV-2 in a Population of Food and Retail Workers Through Transformation of ELISA Datasets
Abdelhadi Djaïleb, Megan-Faye Parker, Étienne Lavallée, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Longitudinal determination of seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through decentralized testing and transformation of ELISA datasets
Abdelhadi Djaïleb, Megan-Faye Parker, Étienne Lavallée, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0314499-e0314499
Open Access | Times Cited: 2

Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial
Dean Follmann, Holly Janes, Olive D. Buhule, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 13

Reported Exposures Among In-Person Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in 6 States, September 2020–June 2021
Hannah Free, Sara E. Luckhaupt, Rachael M. Billock, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_2, pp. S216-S224
Open Access | Times Cited: 11

Cohort Profile: Prospective Cohort to Study the COVID-19 Immune Response in Retail Workers in Québec, Canada (CISACOV)
Kim Santerre, Mathieu Thériault, Nicholas Brousseau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6

Influenza-A mediated pre-existing immunity levels to SARS-CoV-2 could predict early COVID-19 outbreak dynamics
Nerea Martín Almazán, Afsar Rahbar, Marcus Carlsson, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108441-108441
Open Access | Times Cited: 6

Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study
Rebecca Amati, Giovanni Piumatti, Giovanni Franscella, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3703-3703
Open Access | Times Cited: 5

Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases
Sarah Gwyn, Ado Abubakar, Oluwaseun Akinmulero, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 107, Iss. 2, pp. 260-267
Open Access | Times Cited: 9

Infection Rate and Risk Factors of SARS-CoV-2 Infection in Retail Workers at the Onset of the COVID-19 Pandemic, Quebec, Canada
Kim Santerre, Mathieu Thériault, Nicholas Brousseau, et al.
Infectious Disease Reports (2024) Vol. 16, Iss. 6, pp. 1240-1253
Open Access | Times Cited: 1

Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021
Amanda K. Damjanovic, Linda M. Styer, Katherine L. Nemeth, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2227995-e2227995
Open Access | Times Cited: 8

Reported exposure trends among healthcare personnel COVID-19 cases, USA, March 2020–March 2021
Rachael M. Billock, Matthew R. Groenewold, Marie Haring Sweeney, et al.
American Journal of Infection Control (2022) Vol. 50, Iss. 5, pp. 548-554
Open Access | Times Cited: 7

SARS-CoV-2 pandemic in New York metropolitan area: the view from a major urgent care provider
Madhura S. Rane, Angela Profeta, Emily Poehlein, et al.
Annals of Epidemiology (2022) Vol. 74, pp. 31-40
Open Access | Times Cited: 7

Characteristics Associated With a Previous COVID-19 Diagnosis, Vaccine Uptake, and Intention to Be Vaccinated Among Essential Workers in the US Household Pulse Survey
Andrea L. Steege, Sara E. Luckhaupt, Rebecca J. Guerin, et al.
American Journal of Public Health (2022) Vol. 112, Iss. 11, pp. 1599-1610
Open Access | Times Cited: 6

Disproportionate impacts of COVID-19 in a large US city
Spencer J. Fox, Emily Javan, Remy Pasco, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 6, pp. e1011149-e1011149
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top